Synergistic Antitumor Activity of Sorafenib in Combination With Epidermal Growth Factor Receptor Inhibitors in Colorectal and Lung Cancer Cells
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-10-0923
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2010
Authors
Publisher
American Association for Cancer Research (AACR)